Publication Information

{'id': 'https://openalex.org/W1964099428', 'doi': 'https://doi.org/10.1158/1535-7163.pms-b12', 'title': 'Abstract B12: Co-inhibition of PI3K and Myc pathways is synthetic lethal to PTEN null T-ALL leukemia-initiating cells', 'display_name': 'Abstract B12: Co-inhibition of PI3K and Myc pathways is synthetic lethal to PTEN null T-ALL leukemia-initiating cells', 'publication_year': 2013, 'publication_date': '2013-05-01', 'ids': {'openalex': 'https://openalex.org/W1964099428', 'doi': 'https://doi.org/10.1158/1535-7163.pms-b12', 'mag': '1964099428'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.pms-b12', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5075358312', 'display_name': 'Suzanne Schubbert', 'orcid': 'https://orcid.org/0009-0009-5407-8464'}, 'institutions': [{'id': 'https://openalex.org/I1317197149', 'display_name': 'APLA Health', 'ror': 'https://ror.org/05rvwbr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1317197149']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Suzanne Schubbert', 'raw_affiliation_strings': ['1UCLA, LOS ANGELES, CA.'], 'affiliations': [{'raw_affiliation_string': '1UCLA, LOS ANGELES, CA.', 'institution_ids': ['https://openalex.org/I1317197149']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023194786', 'display_name': 'Anjelica Cardenas', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1317197149', 'display_name': 'APLA Health', 'ror': 'https://ror.org/05rvwbr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1317197149']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anjelica Cardenas', 'raw_affiliation_strings': ['1UCLA, LOS ANGELES, CA.'], 'affiliations': [{'raw_affiliation_string': '1UCLA, LOS ANGELES, CA.', 'institution_ids': ['https://openalex.org/I1317197149']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075201811', 'display_name': 'Christopher Wei', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210103595', 'display_name': 'La Jolla Alcohol Research', 'ror': 'https://ror.org/00vvpe721', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I4210103595']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher Wei', 'raw_affiliation_strings': ['2UCSD, La Jolla, CA,'], 'affiliations': [{'raw_affiliation_string': '2UCSD, La Jolla, CA,', 'institution_ids': ['https://openalex.org/I4210103595']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039725334', 'display_name': 'Lingda Ma', 'orcid': None}, 'institutions': [], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Lingda Ma', 'raw_affiliation_strings': ["3Changzhou People's Hospital, Changzhou, China,"], 'affiliations': [{'raw_affiliation_string': "3Changzhou People's Hospital, Changzhou, China,", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111820066', 'display_name': 'Consuelo Garcia', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1324220072', 'display_name': 'Mount Sinai Hospital', 'ror': 'https://ror.org/01zkyz108', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1320796813', 'https://openalex.org/I1324220072']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Consuelo Garcia', 'raw_affiliation_strings': ['4Mount Sinai, New York, NY,'], 'affiliations': [{'raw_affiliation_string': '4Mount Sinai, New York, NY,', 'institution_ids': ['https://openalex.org/I1324220072']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100666444', 'display_name': 'Wei Guo', 'orcid': 'https://orcid.org/0000-0002-9937-7152'}, 'institutions': [{'id': 'https://openalex.org/I99065089', 'display_name': 'Tsinghua University', 'ror': 'https://ror.org/03cve4549', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I99065089']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Wei Guo', 'raw_affiliation_strings': ['5Tsinghua University, Beijing, China.'], 'affiliations': [{'raw_affiliation_string': '5Tsinghua University, Beijing, China.', 'institution_ids': ['https://openalex.org/I99065089']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5112146163', 'display_name': 'Hong Wu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1317197149', 'display_name': 'APLA Health', 'ror': 'https://ror.org/05rvwbr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1317197149']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hong Wu', 'raw_affiliation_strings': ['1UCLA, LOS ANGELES, CA.'], 'affiliations': [{'raw_affiliation_string': '1UCLA, LOS ANGELES, CA.', 'institution_ids': ['https://openalex.org/I1317197149']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '12', 'issue': '5_Supplement', 'first_page': 'B12', 'last_page': 'B12'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10950', 'display_name': 'Acute Lymphoblastic Leukemia research', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10950', 'display_name': 'Acute Lymphoblastic Leukemia research', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9814, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9741, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/null-cell', 'display_name': 'Null cell', 'score': 0.6252707}], 'concepts': [{'id': 'https://openalex.org/C2777609662', 'wikidata': 'https://www.wikidata.org/wiki/Q416356', 'display_name': 'PTEN', 'level': 4, 'score': 0.9340391}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.70412177}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.647278}, {'id': 'https://openalex.org/C86554907', 'wikidata': 'https://www.wikidata.org/wiki/Q285613', 'display_name': 'PI3K/AKT/mTOR pathway', 'level': 3, 'score': 0.6448107}, {'id': 'https://openalex.org/C121853132', 'wikidata': 'https://www.wikidata.org/wiki/Q7068951', 'display_name': 'Null cell', 'level': 3, 'score': 0.6252707}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.46754187}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.2895376}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.26841393}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.20943826}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.14491153}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.104822606}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.pms-b12', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.53}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4287485429', 'https://openalex.org/W4221078301', 'https://openalex.org/W4206884930', 'https://openalex.org/W3120043977', 'https://openalex.org/W2795440402', 'https://openalex.org/W2379132232', 'https://openalex.org/W2133099297', 'https://openalex.org/W2084951351', 'https://openalex.org/W2054836553', 'https://openalex.org/W2001297152'], 'abstract_inverted_index': {'Abstract': [0], 'T-cell': [1], 'acute': [2], 'lymphoblastic': [3], 'leukemia': [4, 87, 159, 228, 388], '(T-ALL)': [5], 'is': [6, 29, 36, 103, 167, 344, 365, 470], 'a': [7, 46, 72, 94, 271, 299, 356, 382], 'common': [8, 30], 'hematological': [9], 'malignancy': [10], 'associated': [11, 37], 'with': [12, 38, 208, 221], 'poor': [13], 'prognosis': [14], 'and': [15, 35, 56, 62, 82, 112, 125, 131, 137, 145, 172, 195, 210, 230, 320, 325, 330, 335, 354, 372, 390, 399, 415, 417, 424, 467], 'significant': [16, 383], 'risk': [17], 'of': [18, 21, 71, 99, 133, 151, 181, 203, 227, 243, 274, 294, 317, 323, 376, 397, 408, 422, 465, 482], 'relapse.': [19], 'Loss': [20], 'PTEN': [22, 429, 474], 'function': [23], 'due': [24], 'to': [25, 40, 52, 64, 104, 109, 169, 217, 266, 288, 312, 347, 360, 394, 444, 473, 491], 'mutations': [26], 'or': [27, 86], 'deletions': [28], 'in': [31, 93, 142, 161, 257, 264, 283, 301, 369, 385, 428], 'primary': [32, 307], 'T-ALL': [33, 50, 60, 67, 138, 196, 206, 277, 300, 310, 343, 379, 413, 431, 476], 'samples': [34], 'resistance': [39, 63], 'therapeutic': [41, 107, 179, 442], 'agents.': [42, 337], 'We': [43, 115, 198, 296, 338], 'previously': [44], 'developed': [45, 298], 'VEC-Cre+;Ptenloxp/loxp': [47], '(Pten': [48], 'null)': [49], 'model': [51], 'investigate': [53], 'the': [54, 83, 129, 152, 178, 233, 289, 292, 318, 350, 387, 395, 406, 410, 483], 'molecular': [55, 123], 'cellular': [57, 319], 'mechanisms': [58, 411], 'underlying': [59, 291, 412], 'pathogenesis': [61], 'therapy.': [65, 402], 'Pten-null': [66], 'develops': [68], 'after': [69], 'acquisition': [70], 'T': [73], 'cell': [74, 333], 'receptor': [75], 'α/δ-c-myc': [76], 'translocation': [77], 'that': [78, 117, 121, 184, 189, 200, 251, 340, 364], 'causes': [79, 224, 381], 'c-Myc': [80], 'over-expression,': [81, 223], 'leukemia-initiating': [84, 477], 'cells,': [85], 'stem': [88], 'cells': [89], '(LSCs),': [90], 'are': [91, 176, 190, 279], 'enriched': [92], 'c-kitmidCD3+': [95], 'subpopulation.': [96], 'The': [97], 'goal': [98], 'our': [100], 'current': [101], 'study': [102], 'develop': [105], 'improved': [106, 441], 'approaches': [108], 'target': [110, 122], 'LSCs': [111, 136, 144, 171, 278], 'eliminate': [113, 170], 'T-ALL.': [114, 147, 173, 447], 'hypothesize': [116], 'small': [118], 'molecule': [119], 'inhibitors': [120], 'lesions': [124], 'pathways': [126, 188, 469], 'required': [127], 'for': [128, 192, 238, 367], 'development': [130, 160, 414], 'survival': [132, 416], 'Pten': [134, 162, 204, 275, 308, 341, 377], 'null': [135, 163, 205, 276, 309, 342, 378, 430, 475], 'may': [139, 286, 438], 'be': [140], 'potent': [141, 419], 'eliminating': [143], 'abolishing': [146], 'Rapamycin,': [148], 'an': [149, 212, 440], 'inhibitor': [150, 215, 352, 358], 'PI3K': [153, 423, 466], 'downstream': [154], 'kinase': [155, 214], 'mTOR,': [156], 'can': [157], 'suppress': [158], 'pre-leukemic': [164], 'mice,': [165], 'but': [166], 'insufficient': [168], 'Therefore,': [174], 'we': [175], 'investigating': [177], 'utility': [180], 'combinational': [182], 'therapies': [183], 'co-target': [185], 'multiple': [186], 'deregulated': [187], 'critical': [191], 'LSC': [193, 234, 391], 'formation': [194], 'survival.': [197], 'found': [199, 339], 'combination': [201, 374, 401, 436], 'treatment': [202, 253, 375], 'mice': [207, 311, 380], 'rapamycin': [209, 324, 398], 'VX-680,': [211, 326], 'Aurora': [213], 'shown': [216], 'have': [218, 297], 'synthetic': [219, 420, 471], 'lethality': [220, 421], 'Myc': [222, 425, 468], 'robust': [225], 'elimination': [226], 'blasts': [229], 'significantly': [231], 'diminishes': [232], 'population.': [235], 'Functional': [236], 'studies': [237], 'leukemia-initiating-cell': [239, 255], 'activity': [240, 256], 'using': [241], 'transplantation': [242], 'treated': [244], 'bone': [245, 258], 'marrow': [246, 259], 'into': [247], 'NOD-SCID-IL2rγ-/-(NSG)': [248], 'recipients': [249], 'showed': [250], 'dual': [252], 'reduced': [254], 'by': [260, 349], 'at': [261], 'least': [262], '100-fold': [263], 'comparison': [265], 'single': [267], 'agent': [268], 'alone.': [269], 'Importantly,': [270, 433], 'large': [272], 'portion': [273], 'actively': [280], 'cycling': [281], '(~50%': [282], 'S-phase),': [284], 'which': [285], 'contribute': [287], 'mechanism': [290], 'efficacy': [293], 'VX-680.': [295], 'vitro': [302], 'culture': [303], 'system': [304], 'derived': [305], 'from': [306], 'conduct': [313], 'more': [314], 'detailed': [315], 'evaluation': [316], 'biochemical': [321], 'effects': [322, 396], 'perform': [327], 'mechanistic': [328], 'analysis,': [329], 'screen': [331], 'additional': [332], 'cycle-directed': [334], 'Myc-targeted': [336], 'highly': [345], 'sensitive': [346], 'killing': [348], 'CDK1': [351], 'purvalanol': [353], 'JQ1,': [355], 'bromodomain': [357], 'reported': [359], 'down-regulate': [361], 'c-myc': [362], 'expression': [363], 'suitable': [366], 'use': [368], 'vivo.': [370], 'Rapamycin': [371], 'JQ1': [373], 'reduction': [384], 'both': [386], 'blast': [389], 'populations,': [392], 'similar': [393], 'VX-680': [400], 'Our': [403], 'results': [404], 'highlight': [405], 'importance': [407], 'understanding': [409], 'show': [418], 'pathway': [426], 'co-inhibition': [427], 'LSCs.': [432], 'such': [434], 'targeted': [435], 'therapy': [437], 'offer': [439], 'approach': [443], 'treat': [445], 'human': [446], 'Citation': [448], 'Format:': [449], 'Suzanne': [450], 'Schubbert,': [451], 'Anjelica': [452], 'Cardenas,': [453], 'Christopher': [454], 'Wei,': [455], 'Lingda': [456], 'Ma,': [457], 'Consuelo': [458], 'Garcia,': [459], 'Wei': [460], 'Guo,': [461], 'Hong': [462], 'Wu.': [463], 'Co-inhibition': [464], 'lethal': [472], 'cells.': [478], '[abstract].': [479], 'In:': [480], 'Proceedings': [481], 'AACR': [484], 'Precision': [485], 'Medicine': [486], 'Series:': [487], 'Synthetic': [488], 'Lethal': [489], 'Approaches': [490], 'Cancer': [492, 503], 'Vulnerabilities;': [493], 'May': [494], '17-20,': [495], '2013;': [496], 'Bellevue,': [497], 'WA.': [498], 'Philadelphia': [499], '(PA):': [500], 'AACR;': [501], 'Mol': [502], 'Ther': [504], '2013;12(5': [505], 'Suppl):Abstract': [506], 'nr': [507], 'B12.': [508]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1964099428', 'counts_by_year': [], 'updated_date': '2024-12-08T13:00:31.739358', 'created_date': '2016-06-24'}